Peptides DB
Research-centric peptide and protocol reference hub
Study 16 of 19HCG (Human Chorionic Gonadotropin) literaturebiorxiv-preprint · Animal study2026

Male fertility is independent of Enh13 control of <i>Sox9</i> testicular expression

Enh13 is essential for starting the male development pathway but not for maintaining male fertility after sex determination in mice.

Read at biorxiv-preprintAdd to compare

Where it sits

this study against the rest of the hcg (human chorionic gonadotropin) corpus
4
Preclinical · this one
14
Observational
0
Open-label
1
Randomised
0
Reviews

Summary and findings

This study investigates the role of the Enh13 enhancer in the regulation of Sox9 expression during testis development in mice. It examines the effects of Enh13 deletion at different developmental stages on male fertility and testis architecture. The findings indicate that Enh13 is critical for initiating the male pathway but not for maintaining fertility post-sex determination.

How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Not reported in abstract.2026

Abstract

The authors’ words, as biorxiv-preprint supplied them

Testis development relies on precise temporal control of Sox9 expression, which is rapidly activated to initiate testis development and subsequently maintained to preserve Sertoli cell identity and male fertility. The distal enhancer, Enh13, is essential for Sox9 upregulation as its constitutive deletion results in complete XY male-to-female sex reversal. Enh13’s requirement across distinct developmental stages remains unexplored. We show that early gonadal deletion of Enh13 fully recapitulates XY sex reversal, demonstrating that Enh13 activity is strictly required to initiate the male pathway. In contrast, Sertoli cell-specific deletion of Enh13 after sex determination has no effect on Sox9 expression, testis architecture, or male fertility, revealing that Enh13 is dispensable for Sox9 maintenance in the differentiated testis. Chromatin accessibility identifies candidate enhancers gaining activity after sex determination, suggesting a regulatory handoff within the Sox9 locus. Finally, we show that duplicating Enh13 in the endogenous mouse locus fails to recapitulate the human XX sex reversal, suggesting that it may not be solely Enh13 sequence duplication that led to XX sex reversal in humans. To the best of our knowledge, this study represents the first in vivo conditional knockout of a developmental enhancer, allowing for temporally controlled interrogation of regulatory logic.

Elsewhere in the HCG (Human Chorionic Gonadotropin) corpus

DComparison of inhalational methoxyflurane, intranasal fentanyl, and intravenous morphine for treatment of prehospital acute pain in Norway (PreMeFen): a randomised, non-inferiority, three-arm, phase 3 trial.Lancet (London, England) · 2026DPreoperative mFOLFIRINOX versus PAXG for stage I-III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results of the first randomisation analysis of a randomised, open-label, 2 × 2 factorial phase 3 trial.Lancet (London, England) · 2026DRussia's health workers complicit in abducting Ukraine's children.Lancet (London, England) · 2026CA proteomic signature of oocyte quality from models of varying oocyte developmental competencebiorxiv-preprint · 2026 · log2FC of ± 1 and a p-value ≤ 0.05 between in vivo and in vitro maturation systems.AnimalBPredictive Value of Day 1–4 β-hCG Change for Single-Dose Methotrexate Failure in Tubal Ectopic Pregnancybiorxiv-preprint · 2026 · Median day 1–4 β-hCG percentage change was +26.4% (IQR 10.9–50.8) in the failure group versus -5.9% (IQR -16.8 to +6.6) in the success group (P<0.001).HumanBRisk factors of Intrauterine Pregnancy Loss Following Surgical of Heterotopic Pregnancy:A Retrospective Analysis of 102 Cases from a Single Centerbiorxiv-preprint · 2026 · 14 (13.73%) experienced miscarriage following surgical treatment, n=102.Human